Human metabolomics: Strategies to understand biology

Current Opinion in Chemical Biology

Volumn 17, Issue 5, 2013, Pages 841-846

  Ramautar, Rawi ^a,b   Berger, Ruud ^a,b   van der Greef, Jan ^a,b,c   Hankemeier, Thomas ^a,b  

^a LEIDEN UNIVERSITY   (Netherlands)

^b NETHERLANDS METABOLOMICS CENTRE   (Netherlands)

^c TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETAINE; BIOLOGICAL MARKER; CARNITINE; CHOLESTEROL; CHOLINE; CREATININE; GLUCOSE; TRIMETHYLAMINE OXIDE; UREA;

ALLOSTASIS; BIOLOGY; CAPILLARY ELECTROPHORESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; ENVIRONMENTAL FACTOR; FATTY ACID OXIDATION; GAS CHROMATOGRAPHY; GENOMICS; HEREDITY; HOMEOSTASIS; HUMAN; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLOMICS; MOLECULAR WEIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHENOTYPE; PROTEOMICS; REVIEW; SOLVENT EXTRACTION; ULTRAFILTRATION;

ANIMALS; BIOLOGICAL MARKERS; HUMANS; METABOLOME; METABOLOMICS; PHENOTYPE;

EID: 84887145976     PISSN: 13675931     EISSN: 18790402     Source Type: Journal    
DOI: 10.1016/j.cbpa.2013.06.015     Document Type: Review

References (49)

1. Nicholson J.K., Wilson I.D. Opinion: understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nature Reviews. Drug Discovery 2003, 2:668-676.
2. Patti G.J., Yanes O., Siuzdak G. Innovation: metabolomics: the apogee of the omics trilogy. Nature Reviews. Molecular Cell Biology 2012, 13:263-269.
3. Kaddurah-Daouk R., Bogdanov M.B., Wikoff W.R., Zhu H., Boyle S.H., Churchill E., Wang Z., Rush A.J., Krishnan R.R., Pickering E., et al. Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo. Translational Psychiatry 2013, 3:e223.
4. Mamas M., Dunn W.B., Neyses L., Goodacre R. The role of metabolites and metabolomics in clinically applicable biomarkers of disease. Archives of Toxicology 2011, 85:5-17.
5. Dunn W.B., Broadhurst D.I., Atherton H.J., Goodacre R., Griffin J.L. Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chemical Society Reviews 2011, 40:387-426.
6. Nicholson J.K., Holmes E., Kinross J.M., Darzi A.W., Takats Z., Lindon J.C. Metabolic phenotyping in clinical and surgical environments. Nature 2012, 491:384-392.
7. Nicholson J.K., Lindon J.C. Systems biology: metabonomics. Nature 2008, 455:1054-1056.
8. van der Greef J., Stroobant P., van der Heijden R. The role of analytical sciences in medical systems biology. Current Opinion in Chemical Biology 2004, 8:559-565.
9. van der Greef J., van Wietmarschen H., van Ommen B., Verheij E. Looking back into the future: 30 years of metabolomics at TNO. Mass Spectrometry Reviews 2013.
10. Nordstrom A., Lewensohn R. Metabolomics: moving to the clinic. Journal of Neuroimmune Pharmacology: the official journal of the Society on NeuroImmune Pharmacology 2010, 5:4-17.
11. Van Q.N., Veenstra T.D. How close is the bench to the bedside? Metabolic profiling in cancer research. Genome Medicine 2009, 1:5.
12. Poste G. Bring on the biomarkers. Nature 2011, 469:156-157.
13. Wikoff W.R., Gangoiti J.A., Barshop B.A., Siuzdak G. Metabolomics identifies perturbations in human disorders of propionate metabolism. Clinical Chemistry 2007, 53:2169-2176.
14. Huber M., Knottnerus J.A., Green L., van der Horst H., Jadad A.R., Kromhout D., Leonard B., Lorig K., Loureiro M.I., van der Meer J.W., et al. How should we define health?. BMJ 2011, 343:d4163.
15. Chen R., Mias G.I., Li-Pook-Than J., Jiang L., Lam H.Y., Miriami E., Karczewski K.J., Hariharan M., Dewey F.E., Cheng Y., et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 2012, 148:1293-1307.
16. Wishart D.S., Jewison T., Guo A.C., Wilson M., Knox C., Liu Y., Djoumbou Y., Mandal R., Aziat F., Dong E., et al. HMDB 3.0-The Human Metabolome Database in 2013. Nucleic Acids Research 2013, 41:D801-D807.
17. Ramautar R., Somsen G.W., de Jong G.J. CE-MS for metabolomics: developments and applications in the period 2010-2012. Electrophoresis 2013, 34:86-98.
18. Kuehnbaum N.L., Britz-McKibbin P. New advances in separation science for metabolomics: resolving chemical diversity in a post-genomic era. Chemical Reviews 2013, 113:2437-2468.
19. Theodoridis G.A., Gika H.G., Want E.J., Wilson I.D. Liquid chromatography-mass spectrometry based global metabolite profiling: a review. Analytica Chimica Acta 2012, 711:7-16.
20. Theodoridis G., Gika H.G., Wilson I.D. Mass spectrometry-based holistic analytical approaches for metabolite profiling in systems biology studies. Mass Spectrometry Reviews 2011.
21. Dunn W.B. Current trends and future requirements for the mass spectrometric investigation of microbial, mammalian and plant metabolomes. Physical Biology 2008, 5:011001.
22. Ramautar R., Busnel J.M., Deelder A.M., Mayboroda O.A. Enhancing the coverage of the urinary metabolome by sheathless capillary electrophoresis-mass spectrometry. Analytical Chemistry 2012, 84:885-892.
23. Quist J., Janssen K.G., Vulto P., Hankemeier T., van der Linden H.J. Single-electrolyte isotachophoresis using a nanochannel-induced depletion zone. Analytical Chemistry 2011, 83:7910-7915.
24. Weber R.J., Southam A.D., Sommer U., Viant M.R. Characterization of isotopic abundance measurements in high resolution FT-ICR and Orbitrap mass spectra for improved confidence of metabolite identification. Analytical Chemistry 2011, 83:3737-3743.
25. Barupal D.K., Haldiya P.K., Wohlgemuth G., Kind T., Kothari S.L., Pinkerton K.E., Fiehn O. MetaMapp: mapping and visualizing metabolomic data by integrating information from biochemical pathways and chemical and mass spectral similarity. BMC Bioinformatics 2012, 13:99.
26. Peironcely J.E., Rojas-Cherto M., Tas A., Vreeken R., Reijmers T., Coulier L., Hankemeier T. Automated pipeline for de novo metabolite identification using mass-spectrometry-based metabolomics. Analytical Chemistry 2013, 85:3576-3583.
27. Rojas-Cherto M., Peironcely J.E., Kasper P.T., van der Hooft J.J., de Vos R.C., Vreeken R., Hankemeier T., Reijmers T. Metabolite identification using automated comparison of high-resolution multistage mass spectral trees. Analytical Chemistry 2012, 84:5524-5534.
28. Menikarachchi L.C., Cawley S., Hill D.W., Hall L.M., Hall L., Lai S., Wilder J., Grant D.F. MolFind: a software package enabling HPLC/MS-based identification of unknown chemical structures. Analytical Chemistry 2012, 84:9388-9394.
29. Uppal K., Soltow Q.A., Strobel F.H., Pittard W.S., Gernert K.M., Yu T., Jones D.P. xMSanalyzer: automated pipeline for improved feature detection and downstream analysis of large-scale, non-targeted metabolomics data. BMC Bioinformatics 2013, 14:15.
30. Christians U., Klawitter J., Hornberger A. How unbiased is non-targeted metabolomics and is targeted pathway screening the solution?. Current Pharmaceutical Biotechnology 2011, 12:1053-1066.
31. Wang Z., Klipfell E., Bennett B.J., Koeth R., Levison B.S., Dugar B., Feldstein A.E., Britt E.B., Fu X., Chung Y.M., et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011, 472:57-63.
32. Koeth R.A., Wang Z., Levison B.S., Buffa J.A., Org E., Sheehy B.T., Britt E.B., Fu X., Wu Y., Li L., et al. Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis. Nature Medicine 2013, 19:576-585.
33. Simo C., Ibanez C., Gomez-Martinez A., Ferragut J.A., Cifuentes A. Is metabolomics reachable? Different purification strategies of human colon cancer cells provide different CE-MS metabolite profiles. Electrophoresis 2011, 32:1765-1777.
34. Leon Z., Garcia-Canaveras J.C., Donato M.T., Lahoz A. Mammalian cell metabolomics: experimental design and sample preparation. Electrophoresis 2013.
35. Vuckovic D. Current trends and challenges in sample preparation for global metabolomics using liquid chromatography-mass spectrometry. Analytical and Bioanalytical Chemistry 2012, 403:1523-1548.
36. Psychogios N., Hau D.D., Peng J., Guo A.C., Mandal R., Bouatra S., Sinelnikov I., Krishnamurthy R., Eisner R., Gautam B., et al. The human serum metabolome. PloS ONE 2011, 6:e16957.
37. Krug S., Kastenmuller G., Stuckler F., Rist M.J., Skurk T., Sailer M., Raffler J., Romisch-Margl W., Adamski J., Prehn C., et al. The dynamic range of the human metabolome revealed by challenges. FASEB Journal: official publication of the Federation of American Societies for Experimental Biology 2012, 26:2607-2619.
38. Bueschl C., Krska R., Kluger B., Schuhmacher R. Isotopic labeling-assisted metabolomics using LC-MS. Analytical and Bioanalytical Chemistry 2013, 405:27-33.
39. Fan T.W., Lorkiewicz P.K., Sellers K., Moseley H.N., Higashi R.M., Lane A.N. Stable isotope-resolved metabolomics and applications for drug development. Pharmacol Ther 2012, 133:366-391.
40. Lane A.N., Fan T.W., Bousamra M., Higashi R.M., Yan J., Miller D.M. Stable isotope-resolved metabolomics (SIRM) in cancer research with clinical application to nonsmall cell lung cancer. OMICS: A Journal of Integrative Biology 2011, 15:173-182.
41. Want E.J., O'Maille G., Smith C.A., Brandon T.R., Uritboonthai W., Qin C., Trauger S.A., Siuzdak G. Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry. Analytical Chemistry 2006, 78:743-752.
42. Bruce S.J., Tavazzi I., Parisod V., Rezzi S., Kochhar S., Guy P.A. Investigation of human blood plasma sample preparation for performing metabolomics using ultrahigh performance liquid chromatography/mass spectrometry. Analytical Chemistry 2009, 81:3285-3296.
43. Dettmer K., Nurnberger N., Kaspar H., Gruber M.A., Almstetter M.F., Oefner P.J. Metabolite extraction from adherently growing mammalian cells for metabolomics studies: optimization of harvesting and extraction protocols. Analytical and Bioanalytical Chemistry 2011, 399:1127-1139.
44. Ala-Korpela M., Kangas A.J., Soininen P. Quantitative high-throughput metabolomics: a new era in epidemiology and genetics. Genome Medicine 2012, 4:36.
45. Suhre K., Meisinger C., Doring A., Altmaier E., Belcredi P., Gieger C., Chang D., Milburn M.V., Gall W.E., Weinberger K.M., et al. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS ONE 2010, 5:e13953.
46. Suhre K., Shin S.Y., Petersen A.K., Mohney R.P., Meredith D., Wagele B., Altmaier E., Deloukas P., Erdmann J., Grundberg E., et al. Human metabolic individuality in biomedical and pharmaceutical research. Nature 2011, 477:54-60.
47. Lenz E.M., Wilson I.D. Analytical strategies in metabonomics. Journal of Proteome Research 2007, 6:443-458.
48. Koek M.M., Jellema R.H., van der Greef J., Tas A.C., Hankemeier T. Quantitative metabolomics based on gas chromatography-mass spectrometry: status and perspectives. Metabolomics: Official Journal of the Metabolomic Society 2011, 7:307-328.
49. Wopereis S., Rubingh C.M., van Erk M.J., Verheij E.R., van Vliet T., Cnubben N.H., Smilde A.K., van der Greef J., van Ommen B., Hendriks H.F. Metabolic profiling of the response to an oral glucose tolerance test detects subtle metabolic changes. PLoS ONE 2009, 4:e4525.